Alan Sebulsky Biography and Net Worth

Director of Parabilis Medicines


Alan Sebulsky is a veteran healthcare portfolio manager and biopharmaceutical investment analyst with more than 40 years of experience in public company investment, financial strategy, portfolio evaluation and growth, and board leadership. He most recently served as Partner and Portfolio Manager at Adage Capital Management, where he led a team overseeing a diversified biopharmaceutical portfolio with over $2 billion in assets. Prior to this, he founded Apothecary Capital, an asset management firm focused on investments across the healthcare and biopharmaceutical sectors.

Alan previously served on the Boards of Directors and Audit Committees for both Jazz Pharmaceuticals and Arrow International, two publicly traded healthcare companies, and on the boards of three private healthcare companies in which Apothecary Capital invested. In these roles, he worked closely with company leadership to advance portfolio, commercial and business strategy.

Alan holds an M.S. in finance and a B.B.A. in finance and economics from the University of Wisconsin–Madison.

What is Alan Sebulsky's net worth?

The estimated net worth of Alan Sebulsky is at least $666.99 thousand as of June 12th, 2026. Mr. Sebulsky owns 20,935 shares of Parabilis Medicines stock worth more than $666,989 as of July 31st. This net worth evaluation does not reflect any other assets that Mr. Sebulsky may own. Learn More about Alan Sebulsky's net worth.

Has Alan Sebulsky been buying or selling shares of Parabilis Medicines?

Alan Sebulsky has not been actively trading shares of Parabilis Medicines over the course of the past ninety days. Most recently, on Monday, June 15th, Alan Sebulsky bought 9,065 shares of Parabilis Medicines stock. The stock was acquired at an average cost of $26.49 per share, with a total value of $240,131.85. Following the completion of the transaction, the director now directly owns 30,000 shares of the company's stock, valued at $794,700. Learn More on Alan Sebulsky's trading history.

Are insiders buying or selling shares of Parabilis Medicines?

In the last twelve months, Parabilis Medicines insiders bought shares 4 times. They purchased a total of 530,000 shares worth more than $10,723,528.30. The most recent insider tranaction occured on June, 15th when Director Alan Sebulsky bought 9,065 shares worth more than $240,131.85. Learn More about insider trades at Parabilis Medicines.

Information on this page was last updated on 6/15/2026.

Alan Sebulsky Insider Trading History at Parabilis Medicines

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2026Buy9,065$26.49$240,131.8530,000View SEC Filing Icon  
6/12/2026Buy8,435$27.67$233,396.4520,935View SEC Filing Icon  
6/11/2026Buy12,500$20.00$250,000.0012,500View SEC Filing Icon  
See Full Table

Alan Sebulsky Buying and Selling Activity at Parabilis Medicines

This chart shows Alan Sebulsky's buying and selling at Parabilis Medicines by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Parabilis Medicines Company Overview

Parabilis Medicines logo
Read More

Today's Range

Now: $31.86
Low: $31.50
High: $32.80

50 Day Range

MA: N/A

2 Week Range

Now: $31.86
Low: $24.51
High: $34.47

Volume

135,008 shs

Average Volume

689,383 shs

Market Capitalization

$3.76 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A